Jefferies Explains its Optimism for Enanta Pharmaceuticals (ENTA) RSV Trial
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/9/2026
- Wall Street posts weekly gains with earnings, inflation data on tap
- Oil prices settle higher as more production shut ahead of hurricane
- Apple cuts iPhone 18 Pro orders due to soft demand, Nikkei Asia reports
- UBS flags level in gold prices where dip buyers will likely emerge
- Telecom stocks tumble on SpaceX spectrum acquisition news
| ENANTA PHARM (NASDAQ: ENTA) | Delayed: 12.50 +0.40 (3.31%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $12.10 | 52 Week High | $34.49 | |||
| Open | $12.07 | 52 Week Low | $20.39 | |||
| Day High | $12.61 | P/E | N/A | |||
| Day Low | $12.07 | EPS | $-3.18 | |||
| Volume | 182,073 | |||||
